Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
ranibizumab 2.0mg
DRUG
2 trials
Sponsors
Eye Center of Northern Colorado, P.C.
, Retina Consultants of Hawaii
Conditions
Polypoidal Choroidal Vasculopathy
Retinal Diseases
Telangiectasis
Phase 1
Safety Study of High-Dose Ranibizumab for Polypoidal Choroidal Vasculopathy
NCT01248117
Retina Consultants of Hawaii
Polypoidal Choroidal Vasculopathy
Start: 2010-11-30
End: 2013-02-28
Target: 20
Updated: 2010-11-25
Phase 2
High-Dose Lucentis (Ranibizumab 2.0mg) for the Treatment of Nonproliferative Idiopathic Parafoveal Telangiectasia
Completed
NCT01205035
Eye Center of Northern Colorado, P.C.
Retinal Diseases, Telangiectasis
Start: 2010-10-31
End: 2012-10-31
Updated: 2015-04-10